Abstract:Highlight • The effective integration of machine learning and genetic algorithms to optimize peptide modifications offers a promising avenue for peptide design. • It introduces novel techniques for the directly modification of small peptides, particularly in cases where insufficient data is available for traditional approaches. • It strategically positions the introduction of positive charge amino acids via our model instead of a mere cumulative addition of positive charged amino-acids. • Minimal modifications to the peptide structure can exert a profound influence on the inhibitory activity of LPS-binding peptides. Introduction Antimicrobial peptides (AMPs) are valuable alternatives to traditional antibiotics, possess a variety of potent biological activities and exhibit immunomodulatory effects that alleviate difficult-to-treat infections. Clarifying the structure-activity relationships of AMPs can direct the synthesis of desirable peptide therapeutics. Objectives In this study, the lipopolysaccharide-binding domain (LBD) was identified through machine learning-guided directed evolution, which acts as a functional domain of the anti-lipopolysaccharide factor family of AMPs identified from Marsupenaeus japonicus . Methods LBD A-D was identified as an output of this algorithm, in which the original LBD Mj sequence was the input, and the three-dimensional solution structure of LBD B was determined using nuclear magnetic resonance. Furthermore, our study involved a comprehensive series of experiments, including morphological studies and in vitro and in vivo antibacterial tests. Results The NMR solution structure showed that LBD B possesses a circular extended structure with a disulfide crosslink at the terminus and two 3 10 -helices and exhibits a broad antimicrobial spectrum. In addition, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that LBD B induced the formation of a cluster of bacteria wrapped in a flexible coating that ruptured and consequently killed the bacteria. Finally, coinjection of LBD B , Vibrio alginolyticus and Staphylococcus aureus in vivo improved the survival of M. japonicus , demonstrating the promising therapeutic role of LBD B for treating infectious disease. Conclusions The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics. Graphical abstract Download : Download high-res image (110KB) Download : Download full-size image Employing machine learning and genetic algorithms, we developed structurally enhanced antimicrobial peptides boasting exceptional efficacy.

Machine Learning Accelerates De Novo Design of Antimicrobial Peptides

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

De novo synthetic antimicrobial peptide design with a recurrent neural network

Machine learning for antimicrobial peptide identification and design

Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning

Combining genetic algorithm with machine learning strategies for designing potent antimicrobial peptides

A foundation model approach to guide antimicrobial peptide design in the era of artificial intelligence driven scientific discovery

Accelerating Antimicrobial Peptide Discovery for WHO Priority Pathogens through Predictive and Interpretable Machine Learning Models

De novo multi-mechanism antimicrobial peptide design via multimodal deep learning

ProT-Diff: A Modularized and Efficient Approach to De Novo Generation of Antimicrobial Peptide Sequences through Integration of Protein Language Model and Diffusion Model

Deep Learning for Novel Antimicrobial Peptide Design

Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides

In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method

Deep learning regression model for antimicrobial peptide design

Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains

Advances in Antimicrobial Peptide Discovery via Machine Learning and Delivery via Nanotechnology

Machine learning-guided discovery and design of non-hemolytic peptides

AMPGAN v2: Machine Learning-Guided Design of Antimicrobial Peptides

Ensemble Machine Learning and Predicted Properties Promote Antimicrobial Peptide Identification

Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides

An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining